Are biotechs underestimating regulatory groundwork
Bio matters
Related Posts
Bio-Rad and Oncocyte partner to develop and commercialise transplant monitoring products
Solid organ transplantation is used to treat end-stage organ failure, including the kidneys Bio-Rad Laboratories and Oncocyte Corporation have partnered to develop and commercialise solid […]
iOnctura achieves new clinical milestones in uveal melanoma therapy
Successful phase 1 study highlights potential of roginolisib iOnctura has announced promising results from the phase 1 DIONE-01 study, showcasing the clinical activity and long-term […]
Purespring Therapeutics secures £80 million in Series B funding
New investment to advance gene therapies for kidney diseases Purespring Therapeutics has raised £80m in an oversubscribed Series B financing round. Syncona Ltd, a leading […]